Therefore, it is promising that enhancement of insulin action in the skeletal muscle, especially suppression of FoxO, is effective in preventing sarcopenia in diabetes and that myokines from the skeletal muscle can be identified and targeted for prevention and treatment of aging-related diseases (Figure 3). The gene discussed is INS; the disease is sarcopenia.